QUDEXY Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Qudexy, and what generic alternatives are available?
Qudexy is a drug marketed by Upsher Smith Labs and is included in one NDA. There are five patents protecting this drug.
The generic ingredient in QUDEXY is topiramate. There are twenty-six drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the topiramate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Qudexy
A generic version of QUDEXY was approved as topiramate by ACCORD HLTHCARE on March 27th, 2009.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for QUDEXY?
- What are the global sales for QUDEXY?
- What is Average Wholesale Price for QUDEXY?
Summary for QUDEXY
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for QUDEXY |
| Drug Sales Revenues: | Drug sales revenues for QUDEXY |
| What excipients (inactive ingredients) are in QUDEXY? | QUDEXY excipients list |
| DailyMed Link: | QUDEXY at DailyMed |
US Patents and Regulatory Information for QUDEXY
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Upsher Smith Labs | QUDEXY XR | topiramate | CAPSULE, EXTENDED RELEASE;ORAL | 205122-001 | Mar 11, 2014 | AB2 | RX | Yes | No | 10,363,224 | ⤷ Start Trial | ⤷ Start Trial | |||
| Upsher Smith Labs | QUDEXY XR | topiramate | CAPSULE, EXTENDED RELEASE;ORAL | 205122-004 | Mar 11, 2014 | AB2 | RX | Yes | No | 8,652,527 | ⤷ Start Trial | Y | ⤷ Start Trial | ||
| Upsher Smith Labs | QUDEXY XR | topiramate | CAPSULE, EXTENDED RELEASE;ORAL | 205122-005 | Mar 11, 2014 | AB2 | RX | Yes | Yes | 9,101,545 | ⤷ Start Trial | Y | ⤷ Start Trial | ||
| Upsher Smith Labs | QUDEXY XR | topiramate | CAPSULE, EXTENDED RELEASE;ORAL | 205122-002 | Mar 11, 2014 | AB2 | RX | Yes | No | 9,555,005 | ⤷ Start Trial | Y | ⤷ Start Trial | ||
| Upsher Smith Labs | QUDEXY XR | topiramate | CAPSULE, EXTENDED RELEASE;ORAL | 205122-001 | Mar 11, 2014 | AB2 | RX | Yes | No | 8,652,527 | ⤷ Start Trial | Y | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
